DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,685,119 | +24.9% | 216,385 | +20.8% | 0.59% | +26.4% |
| Q2 2023 | $42,993,266 | -56.0% | 179,064 | -53.8% | 0.47% | -65.2% |
| Q1 2023 | $97,690,068 | -10.5% | 387,659 | -5.7% | 1.35% | -15.4% |
| Q4 2022 | $109,154,485 | +46.2% | 411,128 | +42.3% | 1.60% | +38.3% |
| Q3 2022 | $74,650,000 | +183.2% | 289,014 | +178.1% | 1.15% | +211.1% |
| Q2 2022 | $26,355,000 | -6.0% | 103,933 | +8.7% | 0.37% | +11.4% |
| Q1 2022 | $28,040,000 | +41.0% | 95,606 | +58.0% | 0.33% | +52.8% |
| Q4 2021 | $19,882,000 | +8.7% | 60,513 | +0.6% | 0.22% | +5.3% |
| Q3 2021 | $18,293,000 | +82.8% | 60,126 | +61.2% | 0.21% | +101.0% |
| Q2 2021 | $10,006,000 | +114.9% | 37,295 | +80.2% | 0.10% | +123.9% |
| Q1 2021 | $4,657,000 | +3.7% | 20,692 | +2.4% | 0.05% | +2.2% |
| Q4 2020 | $4,489,000 | +47.1% | 20,215 | +42.6% | 0.04% | +40.6% |
| Q3 2020 | $3,052,000 | +38.2% | 14,178 | +13.5% | 0.03% | -56.8% |
| Q2 2020 | $2,208,000 | +27.7% | 12,497 | 0.0% | 0.07% | -1.3% |
| Q1 2020 | $1,729,000 | +7.6% | 12,497 | +19.4% | 0.08% | +50.0% |
| Q4 2019 | $1,607,000 | +6.6% | 10,469 | +0.2% | 0.05% | +2.0% |
| Q3 2019 | $1,508,000 | -2.0% | 10,449 | -3.0% | 0.05% | 0.0% |
| Q2 2019 | $1,539,000 | +8.2% | 10,774 | 0.0% | 0.05% | +6.5% |
| Q1 2019 | $1,422,000 | +29.6% | 10,774 | 0.0% | 0.05% | +21.1% |
| Q4 2018 | $1,097,000 | -5.9% | 10,774 | 0.0% | 0.04% | +15.2% |
| Q3 2018 | $1,166,000 | -45.2% | 10,774 | -50.0% | 0.03% | +6.5% |
| Q2 2018 | $2,126,000 | – | 21,548 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |